Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India
Samir Joshi, Rahul Telang, Muralidhar Tambe, Rajesh Havaldar
, Manasi Sane, Afshan Shaikh, Cherry Roy, Kireet Yathati, Sanjaykumar Sonawale, Rupalee Borkar, Rahul Magar, Harshal Bhitkar, Satish Shitole, Leena Nakate, Jyoti Kudrimoti, and Vidya Mave
Author affiliations: Byramjee-Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India (S. Joshi, R. Telang, M. Tambe, R. Havaldar, A. Shaikh, C. Roy, K. Yathati, S. Sonawale, R. Borkar, R. Magar, H. Bhitkar, S. Shitole, L. Nakate, J. Kudrimoti); Byramjee-Jeejeebhoy Government Medical College—Johns Hopkins University Clinical Research Site, Pune (S. Joshi, M. Sane, V. Mave)
Main Article
Figure 1
Figure 1. Frequency of rhino-sino-orbital and cerebral mucormycosis cases evaluated and treated at Sassoon General Hospital, Pune, India, before and during coronavirus disease pandemic. A) January 1, 2016–June 14, 2021; B) September 1, 2020–June 14, 2021.
Main Article
Page created: September 24, 2021
Page updated: December 20, 2021
Page reviewed: December 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.